Parallax Volatility Advisers, L.P. Cure Vac N.V. Transaction History

Parallax Volatility Advisers, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$7.48 - $15.24 $22,215 - $45,262	2,970 Added 10.61%	30,961 $244,000
Q2 2022 Aug 15, 2022	SELL	$13.18 - $19.41 $157,645 - $232,163	-11,961 Reduced 29.94%	27,991 $381,000
Q1 2022 May 16, 2022	SELL	$14.73 - $35.25 $1.4 Million - $3.34 Million	-94,893 Reduced 70.37%	39,952 $783,000
Q4 2021 Feb 14, 2022	BUY	$33.72 - $48.22 $1.81 Million - $2.59 Million	53,655 Added 66.09%	134,845 $4.63 Million
Q3 2021 Nov 15, 2021	BUY	$49.26 - $74.5 $4 Million - $6.05 Million	81,190 New	81,190 $4.44 Million

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $499M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.